Why the study?
Cisplatin-induced nephrotoxicity limits its clinical utility, and quinic acid has cytoprotective and antioxidant properties that may protect against acute kidney injury.
Does quinic acid attenuate cisplatin-induced acute kidney injury in a rat model?
Population
Forty male Wistar rats
Comparison
Control vs cisplatin alone vs cisplatin plus quinic acid (25, 50, or 100 mg/kg)
Design
Randomized animal study with blinded histopathology scoring
Key result
Quinic acid (particularly at 50 and 100 mg/kg) significantly attenuated cisplatin-induced acute kidney injury by improving renal markers, restoring antioxidant capacity, and reducing inflammation.
Authors
Loading...
QA attenuates cisplatin AKI in rats; leaves open translation to human chemotherapy patients.
RCT (n=40)
Single-blind
Randomly divided
Does quinic acid attenuate cisplatin-induced acute kidney injury in a rat model?
Quinic acid demonstrates nephroprotective effects against cisplatin-induced acute kidney injury in rats through antioxidant, anti-inflammatory, and anti-apoptotic mechanisms.
Goudarzi et al. (2026) conducted an RCT in Cisplatin-induced acute kidney injury (n=40). Quinic acid vs. Cisplatin alone and healthy control was evaluated on Biochemical markers of renal dysfunction, oxidative stress indices, inflammatory cytokines, apoptotic gene expression, and Nrf2 pathway proteins. Quinic acid (particularly at 50 and 100 mg/kg) significantly attenuated cisplatin-induced acute kidney injury by improving renal markers, restoring antioxidant capacity, and reducing inflammation.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: